(5-氯吡啶-2-基)-N-甲基甲胺 | 1060802-06-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: (5-氯吡啶-2-基)-N-甲基甲胺
• 英文名称: 1-(5-chloropyridin-2-yl)-N-methylmethanamine
• CAS: 1060802-06-3
• 化学式: C₇H₉ClN₂
• 分子量: 156.615
• InChiKey: LUKUXDRCQOBRAD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  24.9
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  tert-butyl (6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2-yl)carbamate 、 (5-氯吡啶-2-基)-N-甲基甲胺 在 Pd-118 作用下， 以 水 、 乙腈 为溶剂， 生成
  参考文献：
  名称：

  Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα)

  摘要：

  The discovery and optimisation of novel, potent and selective small molecule inhibitors of the alpha-isoform of type III phosphatidylinositol-4-kinase (PI4K alpha) are described. Lead compounds show cellular activity consistent with their PI4K alpha potency inhibiting the accumulation of IP1 after PDGF stimulation and reducing cellular PIP, PIP2 and PIP3 levels. Hence, these compounds are useful in vitro tools to delineate the complex biological pathways involved in signalling through PI4Ka. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.05.093
• 作为产物：
  描述：

  (6-溴苯并[D]噻唑-2-基)氨基甲酸叔丁酯 、 N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinemethanamine 在 Pd-118 作用下， 以 水 、 乙腈 为溶剂， 生成 (5-氯吡啶-2-基)-N-甲基甲胺
  参考文献：
  名称：

  Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα)

  摘要：

  The discovery and optimisation of novel, potent and selective small molecule inhibitors of the alpha-isoform of type III phosphatidylinositol-4-kinase (PI4K alpha) are described. Lead compounds show cellular activity consistent with their PI4K alpha potency inhibiting the accumulation of IP1 after PDGF stimulation and reducing cellular PIP, PIP2 and PIP3 levels. Hence, these compounds are useful in vitro tools to delineate the complex biological pathways involved in signalling through PI4Ka. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.05.093

文献信息

• NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS
  申请人：Barr Kenneth Jay

  公开号：US20160235727A1

  公开（公告）日：2016-08-18

  The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of us ing the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.

  本发明提供了式（I）的化合物、其制药组合物以及使用它们治疗或预防由β3-肾上腺素受体激活介导的疾病的方法。
• [EN] TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS<br/>[FR] DÉRIVÉS DE CARBOXAMIDE TRICYCLIQUES EN TANT QU'INHIBITEURS DE PRMT5
  申请人：AMGEN INC

  公开号：WO2022115377A1

  公开（公告）日：2022-06-02

  Described herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity and may have use in treating proliferative, such as cancer, metabolic and blood disorders. Compounds of Formula (I) have the following structure of Formule (I).

  本文描述了公式（I）的化合物及其药学上可接受的盐，以及其药物组成物。本发明的化合物可用于抑制PRMT5活性，并可用于治疗增殖性疾病，如癌症、代谢和血液疾病。公式（I）的化合物具有以下结构公式（I）。
• [EN] PREPARATION OF SUBSTITUTED 1,2-DIAMINOHETEROCYCLIC COMPOUND DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS<br/>[FR] PRÉPARATION DE DÉRIVÉS DE COMPOSÉS 1,2-DIAMINOHÉTÉROCYCLIQUES SUBSTITUÉS ET LEUR UTILISATION EN TANT QU'AGENTS PHARMACEUTIQUES
  申请人：AVELOS THERAPEUTICS INC

  公开号：WO2022260441A1

  公开（公告）日：2022-12-15

  This invention relates to compounds which are microtubule associated serine/threonine-like kinase (MASTL) inhibitors and the use of the compounds in the treatment of diseases and medical conditions mediated by MASTL, for example in the treatment of cancer and other target related diseases.

  本发明涉及一种微管相关丝氨酸/苏氨酸样激酶（MASTL）抑制剂化合物及其在治疗由MASTL介导的疾病和医学状况中的应用，例如在治疗癌症和其他相关疾病中的应用。
• PYRAZOLO(3,4-B)PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
  申请人：GLAXO GROUP LIMITED

  公开号：EP1539753B1

  公开（公告）日：2009-09-09
• PRO-SURVIVAL COMPOUNDS
  申请人：University Court of The University of Glasgow

  公开号：US20170362184A1

  公开（公告）日：2017-12-21

  Disclosed herein are a class of compounds useful in cell culture, in particular, the in vitro culture of stem cells. The compounds have been found to promote the survival and/or maintenance of stem cells in (or during) culture and/or throughout passage.